FDA Pilot Program Eases Rules for Nicotine Pouch Makers 
Air Canada Express Crash at LaGuardia: Controller Distracted by Prior Emergency 
Amazon's "Transformer" Phone: Can It Succeed Where Fire Phone Failed? 
FCC Chairman Threatens Broadcasters Over "Fake News" Amid Iran War Coverage Debate 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Meta Ties Executive Pay to Aggressive Stock Price Targets in Major Retention Push 
U.S. Pulls Back Proposed AI Chip Export Rule Amid Policy Uncertainty 
U.S. Deploys Elite 82nd Airborne Troops to Middle East Amid Iran Tensions 
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options 
US Accelerates Taiwan Arms Deliveries Amid Rising China Threat 
Trump's Overhaul of American History: Museums, Monuments, and Cultural Institutions 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
Cyberattack on Stryker Triggers U.S. Government Warning Over Microsoft Intune Security 
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now 
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency 
ICE Arrest of Guatemalan Woman at San Francisco Airport Sparks Outrage 
Tesla FSD EU Approval Delayed to April 10 as RDW Completes Final Review 
U.S. President Donald Trump has signed an executive order aimed at expanding the use of artificial intelligence (AI) in pediatric cancer research. The order provides an additional $50 million in research grants to accelerate progress in finding cures for childhood cancers, according to White House officials.
This move builds on the National Cancer Institute’s (NCI) Childhood Cancer Data Initiative, a decade-long, $500 million program launched in 2019 to collect and share vital data on pediatric cancers. Michael Kratsios, director of the White House Office of Science and Technology Policy, highlighted that childhood cancer remains the leading cause of disease-related deaths among children in the United States, with cases rising more than 40% since 1975.
Kratsios noted that advances in AI can now be harnessed to sharpen diagnoses, improve clinical trials, fine-tune treatment strategies, and enhance prevention methods. Data gathered through the NCI initiative is expected to empower researchers with new tools to tackle the complexity and diversity of pediatric cancers.
In addition to the $50 million in grants, the National Institutes of Health (NIH) will double its commitment by investing another $50 million. This funding aims to attract leading scientific teams through competitive research opportunities. Further investments are also anticipated to strengthen ongoing initiatives.
The announcement comes despite Trump’s 2026 budget proposal, which suggested a 37% cut to the NCI budget. Lawmakers in both the House and Senate, however, have pushed back against these cuts, and budget negotiations remain ongoing.
Globally, the World Health Organization reports that around 400,000 children and adolescents are diagnosed with cancer each year. While advances in adult cancer research have surged with AI, pediatric cancer research has lagged due to challenges like cancer rarity, diversity, and ethical concerns over patient data protection.
By reinforcing funding and leveraging AI, the administration aims to close this gap and accelerate life-saving innovations in childhood cancer treatment.
